For laboratories and research institutions seeking efficient, accurate detection of gentamicin, the Gentamicin One-Step Competitive ELISA Kit from Antbio Inc. stands as a reliable solution. This advanced kit is engineered to streamline the gentamicin detection process, integrating a one-step workflow that significantly reduces operational time compared to traditional ELISA methods—eliminating complex multi-step procedures while maintaining exceptional precision.
Designed with user-friendliness in mind, the kit includes all essential components (pre-coated plates, reagents, standards, etc.) to ensure consistent performance across different operators and laboratory settings. It delivers high sensitivity and specificity, enabling the detection of gentamicin in various sample types (such as food matrices, biological fluids, or environmental samples) with low detection limits, meeting the rigorous requirements of quality control, regulatory testing, and scientific research.
Backed by Antbio Inc.’s expertise in developing high-performance immunoassay products, this kit adheres to strict manufacturing standards, ensuring batch-to-batch consistency and reliable results you can trust. Whether for routine screening or critical analytical tasks, it empowers users to achieve efficient, accurate gentamicin detection with minimal effort.
| Antigen |
Gentamicin |
| Immunogen |
Recombinant Protein |
| Antibody Type |
Recombinant mAb |
| Reactivity |
Others |
| Purification |
Protein A |
| Stability & Storage |
2 to 8 ℃ as supplied.
|
Gentamicin is an aminoglycoside antibiotic. It became a critical therapeutic agent due to its broad-spectrum activity against Gram-negative bacteria (e.g., Pseudomonas aeruginosa, Escherichia coli, Klebsiella) and some Gram-positive pathogens. As a bactericidal drug, gentamicin inhibits protein synthesis by binding to the 30S ribosomal subunit, disrupting mRNA translation and causing premature termination or misreading of genetic code. Clinically, it is used to treat severe infections such as sepsis, pneumonia, intra-abdominal infections, and complicated urinary tract infections. It is often combined with β-lactam antibiotics (e.g., penicillins or cephalosporins) for synergistic effects. However, its use is limited by dose-dependent nephrotoxicity and ototoxicity (hearing loss, vestibular damage), necessitating careful monitoring of renal function and serum drug levels.
中文
